Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis”

522 trials

Showing 20 of 522 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Testing effectiveness (Phase 2)Study completedNCT04893707
What this trial is testing

The Study of CM310 in Patients With Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Keymed Biosciences Co.Ltd 127
Testing effectiveness (Phase 2)Ended earlyNCT03847389
What this trial is testing

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hill Dermaceuticals, Inc. 8
Not applicableLooking for participantsNCT06988605
What this trial is testing

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Who this might be right for
Atopic Dermatitis
Galderma R&D 1,000
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Not applicableUnknownNCT04087863
What this trial is testing

Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT00817063
What this trial is testing

Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema

Who this might be right for
Eczema
Stiefel, a GSK Company 599
Large-scale testing (Phase 3)Study completedNCT04875169
What this trial is testing

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 336
Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Not applicableStudy completedNCT05203380
What this trial is testing

Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Regeneron Pharmaceuticals 45
Testing effectiveness (Phase 2)UnknownNCT04512339
What this trial is testing

Dupilumab in Severe Chronic Hand Eczema

Who this might be right for
Hand Eczema
University Medical Center Groningen 30
Testing effectiveness (Phase 2)Study completedNCT03562377
What this trial is testing

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Who this might be right for
Atopic Dermatitis
LEO Pharma 215
Testing effectiveness (Phase 2)Active Not RecruitingNCT07220577
What this trial is testing

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Ended earlyNCT05999799
What this trial is testing

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 161
Post-approval studies (Phase 4)Study completedNCT05624112
What this trial is testing

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China

Who this might be right for
Atopic DermatitisDermatitis Atopic
Sanofi 44
Early research (Phase 1)Looking for participantsNCT06564389
What this trial is testing

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis
Pfizer 119
Large-scale testing (Phase 3)Study completedNCT02755649
What this trial is testing

Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 325
Large-scale testing (Phase 3)UnknownNCT06026891
What this trial is testing

Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Shanghai Mabgeek Biotech.Co.Ltd 498
Large-scale testing (Phase 3)Study completedNCT03131648
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 802
Testing effectiveness (Phase 2)Study completedNCT04212169
What this trial is testing

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AstraZeneca 148
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation